Cited by 76Cardiomyopathy and Myosin StudiesHeart Failure Treatment and ManagementViral Infections and Immunology Research

Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies

Open access
Givertz, Michael M., Mann, Douglas L.·2013·Current Heart Failure Reports

Abstract

Although the long term prognosis of patients with dilated cardiomyopathy (DCM) remains poor, approximately 25 % of DCM patients with recent onset of heart failure (< 6 months) have a relatively benign clinical course with a spontaneously improvement in symptoms and partial, or in some cases complete, recovery of left ventricular (LV) function. Despite the longstanding recognition of the clinical phenomenon of LV recovery, relatively little attention has been paid to the etiology and natural history of this important group of DCM patients. Accordingly, in the present review we will focus on the epidemiology and natural history of recent onset DCM in patients who undergo spontaneous resolution of symptoms that is accompanied by recovery of LV function.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11897-013-0157-5

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide and continue to impose staggering financial burden on healthcare systems.

    “Despite advancements in clinical management, MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide 3,4 and continue to impose staggering financial burden on healthcare systems 3,5-8 .”

    From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [7]

    The Epidemiology of LV Recovery section mentions ischemic heart failure only in discussing recovery of ventricular function; it does not describe MI or ischemic cardiomyopathy as leading causes of heart failure, morbidity, or death. Searches for MI, ischemic cardiomyopathy, worldwide burden, and healthcare costs found no passage addressing those claims. (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 76

Research works printed but not linked: 1

  1. Mann DL Barger PM Burkhoff D Myocardial recovery: myth, magic or molecular target? J Amer Coll Cardiol 2012 60 2465 2472 Recent article that addresses the biology of LV recovery and reverse remodeling and that introduces the concept that end organ damage prevents restoration of LV function. 23158527 PMC3522780

Authors
Givertz, M. M., & Mann, D. L.
Affiliations
  • Brigham and Women's Hospital (US)
  • Washington University in St. Louis (US)
Corresponding author
Mann, Douglas L.
Venue
Current Heart Failure Reports
Published
2013-09-08
Volume
10
Issue
4
Pages
321-330
ISSN
  • 1546-9530 (ISSN-L)
  • 1546-9549
OpenAlex
W1983112986
Cited by
76
References
70
Citations by year
2026: 2 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Current Heart Failure Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL111094, R01HL089543, R01 HL89543)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
Keywords
dilated cardiomyopathy, left ventricular function recovery, natural history (disease), heart failure, prognosis, epidemiology
MeSH terms
Cardiomyopathy, Dilated, Humans, Myocarditis, Prognosis, Remission, Spontaneous, Ventricular Function, Left, Systemic Inflammatory Response Syndrome, Recovery of Function, Cardiotoxins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review